Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases

Non-vitamin K antagonist oral anticoagulants (NOACs) have a favorable benefit-risk profile compared with vitamin K antagonists. However, the lack of specific reversal agents has made the management of some patients receiving long-term treatment with NOACs problematic in emergency situations such as...

Descripción completa

Detalles Bibliográficos
Autores principales: Vosko, Milan R., Bocksrucker, Christof, Drwiła, Rafał, Dulíček, Petr, Hauer, Tomas, Mutzenbach, Johannes, Schlimp, Christoph J., Špinler, David, Wolf, Thomas, Zugwitz, Daša
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337234/
https://www.ncbi.nlm.nih.gov/pubmed/28210988
http://dx.doi.org/10.1007/s11239-017-1476-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337234/
https://www.ncbi.nlm.nih.gov/pubmed/28210988
http://dx.doi.org/10.1007/s11239-017-1476-2

Ejemplares similares